Capital Research Global Investors Dexcom Inc Transaction History

Capital Research Global Investors

$440 Billion
Q1 2025

A detailed history of Capital Research Global Investors transactions in Dexcom Inc stock. As of the latest transaction made, Capital Research Global Investors holds 12,036,698 shares of DXCM stock, worth $1.03 Billion. This represents 0.19% of its overall portfolio holdings.

Number of Shares

12,036,698

Previous 14,371,751 16.25%

Holding current value

$1.03 Billion

Previous $1.12 Billion 26.46%

% of portfolio

0.19%

Previous 0.24%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$67.74 - $90.75 $158 Million - $212 Million	-2,335,053 Reduced 16.25%	12,036,698 $822 Million
Q4 2024 Feb 13, 2025	SELL	$65.68 - $81.01 $235 Million - $290 Million	-3,576,503 Reduced 19.93%	14,371,751 $1.12 Billion
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $384 Million - $697 Million	6,002,727 Added 50.25%	17,948,254 $1.2 Billion
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $164 Million - $209 Million	-1,490,365 Reduced 11.09%	11,945,527 $1.35 Billion
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $212 Million - $261 Million	-1,860,140 Reduced 12.16%	13,435,892 $1.86 Billion
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $203 Million - $335 Million	2,695,296 Added 21.39%	15,296,032 $1.9 Billion
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $300 Million - $481 Million	3,484,190 Added 38.22%	12,600,736 $1.18 Billion
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $17.8 Million - $20.7 Million	-158,069 Reduced 1.7%	9,116,546 $1.17 Billion
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $19.4 Million - $23 Million	-186,930 Reduced 1.98%	9,274,615 $1.08 Billion
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $90.8 Million - $131 Million	-1,068,693 Reduced 10.15%	9,461,545 $1.07 Billion
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $217 Million - $268 Million	2,847,171 Added 37.06%	10,530,238 $848 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $343 Million - $670 Million	5,040,557 Added 190.75%	7,683,067 $573 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $25.2 Million - $34.9 Million	267,965 Added 11.28%	2,642,510 $1.35 Billion
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $110 Million - $138 Million	844,916 Added 55.24%	2,374,545 $1.28 Billion
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $10.5 Million - $14 Million	98,034 Added 6.85%	1,529,629 $836 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $83.9 Million - $112 Million	1,036,207 Added 262.07%	1,431,595 $611 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $33.5 Million - $41.4 Million	395,388 New	395,388 $142 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $9.72 Million - $13.5 Million	-360,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $8.41 Million - $13.2 Million	360,000 New	360,000 $51.5 Million

Others Institutions Holding DXCM

# of Institutions

1,079

Shares Held

360M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Dexcom Inc Transaction History